4 Stocks to Watch for Lasting Generational Wealth

Creating generational wealth through stocks is not about short-term price moves.

Over the long run, strong businesses tend to share a few common traits: they operate in growing sectors, deliver consistent sales and profit growth, convert profits into real cash flows, and are led by committed promoters with skin in the game.

Such fundamentals decide which companies can sustain long-term wealth creation across market cycles.

In this editorial, we will break down four stocks to watch for lasting generational wealth, backed by strong business models, sector tailwinds, and improving financials.

#1 BSE Ltd

The first stock is BSE, which is Asia's oldest stock exchange and one of the fastest-growing market platforms today.

It provides a high-speed ecosystem where investors and institutions trade shares, bonds, and derivatives every day. Most people know BSE because of its flagship index, the Sensex, but the business goes much deeper than that.

BSE runs BSE StAR MF, India's largest mutual fund distribution platform, which handles close to 90% of the industry's transactions. It's also a market leader in SME listings, helping smaller companies raise capital and grow.

Over the last few years, BSE has strengthened its position as a core market infrastructure institution.

After relaunching Sensex and Bankex derivative contracts, it has emerged as the world's second-largest exchange in index derivatives.

Growth Drivers

The management is focused on bringing more participants into the market and increasing liquidity.

A key part of this strategy is deeper engagement with foreign portfolio investors (FPIs) and large institutions, especially in monthly and longer-duration derivative contracts, where volumes can scale sustainably over time.

To meet rising demand from high-frequency and institutional traders, BSE is also expanding its co-location infrastructure to around 500 racks, improving speed, capacity, and operating leverage.

From a risk-management perspective, the introduction of voluntary 5% core SGF contributions from transaction revenues adds financial discipline.

BSE Financial Performance

Financial Snapshot (FY22 - H1FY26)

Source: Company Financial Results

Over the last few years, BSE has seen a very strong financial performance. Revenue has scaled up, reaching Rs 32,120 m in FY25, largely because of a strong jump in derivative trading volumes.

At the same time operating margins improved from around 34% to nearly 62%, showing the power of operating leverage.

As more traders and institutions use the platform, costs don't rise at the same pace, allowing a larger share of revenue to flow directly to profits.

Cash flows did see some pressure in FY23, but that's temporary, and by FY24, cash generation recovered strongly, and the momentum has continued into H1 FY25 too, and cash generation remains healthy.

#2 Premier Energies Ltd

The second stock is Premier Energies, which is a fully integrated manufacturer of high-efficiency solar cells, modules, and panels.

What sets the company apart is its technology leadership. It was the first Indian firm to manufacture TOPCon solar cells.

The business also offers strong revenue visibility. Its Rs 132.5 bn domestic order book shows clear demand for the coming years, reducing uncertainty around capacity utilisation.

Over time, Premier has been rapidly integrating across the solar value chain, which helps control costs and improve margins.

Growth Outlook

The management has accelerated its long-term roadmap under "Mission 2028", achieving key milestones 18 months ahead of schedule.

The company now targets an integrated capacity of 10.6 GW in solar cells and 11.1 GW in modules by September 2026. Growth is being achieved by backward integration into ingot and wafer manufacturing, which is expected to improve supply security and cost efficiency.

At the same time, Premier is expanding into allied segments such as inverters and transformers, moving beyond pure solar manufacturing. Over the medium term, these new verticals are expected to contribute 25-30% of group revenues, adding diversification to the business model.

Premier Energies Financial Analysis

Financial Snapshot (FY22 - H1FY26)

Source: Company Financial Results

Premier Energies has gone through a positive trend over the last few years. The company moved from net losses to strong profitability, with revenue nearly doubling every year since FY23, because of rising capacity and better product mix.

Profitability has improved after the shift to high-efficiency TOPCon technology. Operating margins also expanded from around 4% to nearly 30%, showing how technology upgradation and scale have changed the earnings profile of the business.

Cash flow quality also looks healthy. In FY25, the CFO-to-PAT ratio stood at 1.44, which means the company is generating more cash than accounting profits. This shows strong cash conversion, disciplined working capital management, and high-quality earnings.

#3 Natco Pharma Ltd

The third company in our list is Natco Pharma, which is a well-established, vertically integrated pharma company with a strong focus on complex generics and niche products that have high entry barriers.

The business operates across three main segments: Finished Dosage Formulations (FDF), Active Pharmaceutical Ingredients (API), and the growing Crop Health Sciences (CHS) division. The product portfolio covers specialised therapies in cancer, cardiology, and diabetology.

The company has built a leadership position in India's oncology segment and also has a wide global presence across more than 50 countries. Exports form a major part of the business, contributing close to 78% of total revenues, which reduces dependence on any single market.

Growth Outlooks

The management expects FY26 to be stable and resilient, even with rising competition in the US market.

For the full year, the company has guided for Profit After Tax (PAT) in the range of Rs 12,750-13,000 m.

One of the biggest potential value unlocks ahead is the demerger of the Crop Health (Agrochemicals) business, which is planned for 2026. This move will create a separate listed entity, allowing both the pharma and agro businesses to grow independently and be valued more transparently by the market.

Growth will also be supported by the acquisition of Adcock Ingram in South Africa, which helps diversify revenues beyond the US and adds stability during periods of pricing pressure in regulated markets.

On the product side, the pipeline remains strong, with upcoming complex launches such as Semaglutide and multiple Sole First-to-File opportunities, which could support margins and earnings over the medium term.

Natco Pharma Financial Analysis

Financial Snapshot (FY22 - H1FY26)

Source: Company Financial Results

NATCO Pharma has delivered strong growth over the last few years, with revenue more than doubling since FY22. The real standout, however, has been the improvement in profitability.

Operating profit margins improved from around 17.7% to over 53% by FY25, reflecting the company's increasing focus on high-margin, niche generic products rather than commoditised formulations. This shift has fundamentally changed the earnings profile of the business.

Cash flow quality remains healthy. In H1 FY26, the CFO-to-PAT ratio stood at 1.19, indicating that profits are backed by real cash generation and disciplined working capital management.

4# DOMS Industries Ltd

The last stock is DOMS Industries, which was incorporated in 2006, and is the second-largest branded stationery and art products company in India.

Over the years, the company has built a strong presence in core categories, with around 29% market share in pencils and 30% share in mathematical instrument boxes as of FY23.

DOMS has a wide and diversified product portfolio, with more than 4,500 SKUs across scholastic stationery, art and craft materials, paper-based products, and office supplies. This broad range helps the company stay relevant across age groups, from school children to working professionals.

One of DOMS' strengths is its strategic partnership with F.I.L.A., a global art materials player. This partnership gives DOMS access to international R&D capabilities, premium products, and global distribution know-how.

Recently, the company has also taken its first step outside stationery by entering the baby hygiene segment through the acquisition of Uniclan Healthcare, opening up a new long-term growth avenue beyond its core business.

Growth Outlook

The management has guided for 18-20% consolidated sales growth in FY26, indicating confidence in demand across core stationery and new product categories.

Profitability is expected to remain stable, with EBITDA margins guided at 16.5-17.5% and PAT margins around 10-10.5%.

One of the growth drivers ahead is the 44-acre expansion project at Umbergaon. Commercial production from this facility is expected to begin in Q1 FY27, which will significantly increase capacity, especially for high-volume products such as pencils.

Alongside capacity expansion, the company is focused on deepening its retail reach across India. It's also widening its "back-to-school" product range, adding categories like school bags and hygiene products.

DOMS Industries Financial Analysis

Financial Snapshot (FY22 - H1FY26)

Source: Company Financial Results

DOMS Industries has delivered steady growth in both revenue and profits as volumes increased and operating leverage increased; profitability also improved meaningfully.

The operating profit margin (OPM) expanded from 10.2% to a range of 17.5-18.2%, showing better cost control, improved product mix, and scale benefits in manufacturing and distribution.

Cash flow did see some pressure in FY25, mainly because of higher working capital requirements linked to expansion plans.

However, this proved to be temporary. By H1 FY26, the CFO-to-PAT ratio rebounded strongly, indicating efficient cash management and healthy conversion of profits into cash.

Conclusion

As India's economy expands over the coming years, a few businesses are positioned to grow consistently and strengthen their competitive advantages.

These five stocks for generational wealth stand out due to scalable models, improving cash flows, and long-term sector tailwinds.

For long-term investors, tracking business execution and financial performance will remain key as these companies evolve over time.

To know what's moving the Indian stock markets today, check out the most recent share market updates here.

Investors should evaluate the company's fundamentals, corporate governance, and valuations of the stock as key factors when conducting due diligence before making investment decisions.

Disclaimer: This article is for information purposes only. It is not a stock recommendation and should not be treated as such. Learn more about our recommendation services here...